Cite

The Transmembrane Protease Serine (TMPRSS3/TADG-12) D Variant: A Potential Candidate for Diagnosis and Therapeutic Intervention in Ovarian Cancer

MLA

Sawasaki, T., et al. “The Transmembrane Protease Serine (TMPRSS3/TADG-12) D Variant: A Potential Candidate for Diagnosis and Therapeutic Intervention in Ovarian Cancer.” Tumor Biology, vol. 25, no. 3, Mar. 2004, pp. 141–48. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs6389873&authtype=sso&custid=ns315887.



APA

Sawasaki, T., Shigemasa, K., Gu, L., Beard, J. B., & O’Brien, T. J. (2004). The Transmembrane Protease Serine (TMPRSS3/TADG-12) D Variant: A Potential Candidate for Diagnosis and Therapeutic Intervention in Ovarian Cancer. Tumor Biology, 25(3), 141–148.



Chicago

Sawasaki, T., K. Shigemasa, L. Gu, J.B. Beard, and T.J. O’Brien. 2004. “The Transmembrane Protease Serine (TMPRSS3/TADG-12) D Variant: A Potential Candidate for Diagnosis and Therapeutic Intervention in Ovarian Cancer.” Tumor Biology 25 (3): 141–48. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs6389873&authtype=sso&custid=ns315887.